gsk-126

GSK-126 inhibit EZH2 activity - first potential POTS cure Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.119.315654 Resources...